Lastest Insider Transactions Of Lineage Cell Therapeutics, Inc. ( LCTX ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | General Counsel/Secretary | 2024-02-11 | Option Exercise | 6,076 | 0.00 | 0 | 2024-02-12 21:30:12 |
LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2024-02-11 | Option Exercise | 31,249 | 0.00 | 0 | 2024-02-12 21:27:33 |
LCTX | Lineage Cell Therapeutics, Inc. | BAILEY DON M | Directior | 2024-02-08 | Buy | 96,155 | 1.04 | 100,001 | 2024-02-08 19:00:09 |
LCTX | Lineage Cell Therapeutics, Inc. | BAILEY DON M | Directior | 2024-02-08 | Buy | 96,155 | 1.04 | 100,001 | 2024-02-08 19:00:09 |
LCTX | Lineage Cell Therapeutics, Inc. | BROADWOOD PARTNERS, L.P. | Directior 10% Owner | 2024-02-06 | Buy | 6,730,770 | 1.04 | 7,000,001 | 2024-02-08 18:58:18 |
LCTX | Lineage Cell Therapeutics, Inc. | Jayasuriya Anula | Directior | 2023-12-29 | Buy | 10,000 | 1.09 | 10,900 | 2024-01-02 19:08:49 |
LCTX | Lineage Cell Therapeutics, Inc. | Culley Brian M | President and CEO | 2023-02-11 | Option Exercise | 31,249 | 0.00 | 0 | 2023-02-14 16:15:52 |
LCTX | Lineage Cell Therapeutics, Inc. | Samuel George A. III | General Counsel/Secretary | 2023-02-11 | Option Exercise | 6,076 | 0.00 | 0 | 2023-02-14 16:15:47 |
LCTX | Lineage Cell Therapeutics, Inc. | Hogge Gary S. | SVP,Clinical & Medical Affairs | 2023-02-11 | Option Exercise | 13,020 | 0.00 | 0 | 2023-02-14 16:15:41 |